Skip to content

Behavioral and Neuronal Correlates of Human Mood States

Behavioral and Neuronal Correlates of Human Mood States

Status
Completed
Phases
Unknown
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT06159595
Enrollment
11
Registered
2023-12-07
Start date
2023-12-01
Completion date
2025-11-07
Last updated
2026-05-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Epilepsy, Major Depressive Disorder

Brief summary

Optimizing treatments in mental health requires an easy to obtain, continuous, and objective measure of internal mood. Unfortunately, current standard-of-care clinical scales are sparsely sampled, subject to recency bias, underutilized, and are not validated for acute mood monitoring. The recent shift to remote care also requires novel methods to measure internal mood. Recent advances in computer vision have allowed the accurate quantification of observable speech patterns and facial representations. The continuous and objective nature of these audio-facial behavioral outputs also enable the study of their neural correlates. Here, the investigators hypothesize that video-derived audio-facial behaviors have discrete neural representations in the limbic network and can provide a critical set of reliable longitudinal estimates of mood at low cost across home and clinic settings.

Interventions

Surgically-implanted intracranial electrodes.

Sponsors

Stanford University
Lead SponsorOTHER
National Institute of Mental Health (NIMH)
CollaboratorNIH

Study design

Allocation
RANDOMIZED
Intervention model
CROSSOVER
Primary purpose
BASIC_SCIENCE
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
18 Years to 65 Years
Healthy volunteers
No

Inclusion criteria

* Age range between 18 and 65 * Major depressive disorder (MDD) in a current major depressive episode diagnosed with the Mini-International Neuropsychiatric Interview (MINI) * No medical or surgical contraindication to electrode implantation * Patient capable of understanding the scope of our project or signing informed consent independently.

Exclusion criteria

* Diffuse epilepsy involving several lobes of the brain

Design outcomes

Primary

MeasureTime frameDescription
Quantitative Audio-Facial Change5 minutesQuantitative percent change in each audio-facial feature before and after direct electrical stimulation at each site.
Quantitative Mood Change5 minutesQuantitative percent change in Immediate Mood Scaler (IMS) after direct electrical stimulation at each site compared to a baseline period before sham. The minimum score on the IMS is 7 and the maximum is 154, with lower scores reflecting more negative mood states.

Secondary

MeasureTime frameDescription
Correlation between Audio-Facial and Mood Change5 minutesQuantitative audio facial changes will be compared to quantitative changes in mood at each site by means of correlation and binary comparisons.
Qualitative Mood Change5 minutesQualitative articulation of mood (participants freely articulate mood after direct electrical stimulation at each site) and speech transcripts will be analyzed for ratio of positive and negative valence words.

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: May 23, 2026